Market Overview The prothrombin complex concentrate PCC market is expanding as hemophilia B and rare bleeding disorder indications broaden beyond traditional warfarin reversal. The Prothrombin Complex Concentrate PCC Market is projected to grow through 2035, driven by factor IX deficiency treatment, inhibitor bypass therapy, and rare coagulation factor deficiencies supporting PCC adoption...